Stay updated on GB5121 in Refractory CNS Lymphoma Clinical Trial

Sign up to get notified when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GB5121 in Refractory CNS Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T19:13:52.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now shown, replacing the study record content and indicating that access to the page is blocked.
    Difference
    17%
    Check dated 2026-09-19T19:13:48.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.6.6 is now displayed, replacing the previous Revision: v3.6.5. This reflects a minor update to the page's revision label rather than any content change to the study details.
    Difference
    0.1%
    Check dated 2026-08-29T20:04:24.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page footer revision was updated from v3.6.4 to v3.6.5, indicating a new release of the page. This update reflects version control rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-08T10:48:50.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The sponsor entity name was updated to Gossamer Bio USA, Inc. (GB005, Inc.), and the page revision progressed from v3.6.3 to v3.6.4.
    Difference
    0.2%
    Check dated 2026-07-25T06:46:01.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3 in place of Revision: v3.6.2, indicating an update to the interface version. This is a UI/versioning change and does not alter the study data or its presentation beyond the version label.
    Difference
    0.1%
    Check dated 2026-07-03T21:53:46.000Z thumbnail image

Stay in the know with updates to GB5121 in Refractory CNS Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.